MVP Act

Hozzl · 2022-12-29T23:03:27Z

Explore the details of House Bill 7389 MVP Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/29/2022, 11:03 PM

Summary of Bill HR 7389

The MVP Act, also known as Bill 117 hr 7389, is a piece of legislation introduced in the US Congress. The main purpose of this bill is to provide support and resources for veterans who have experienced military sexual trauma (MST).

The MVP Act aims to improve the Department of Veterans Affairs' (VA) response to MST by requiring the VA to provide specialized training for VA employees who work with veterans who have experienced MST. This training will focus on understanding the unique needs of these veterans and providing appropriate care and support.

Additionally, the MVP Act seeks to increase access to mental health services for veterans who have experienced MST. The bill requires the VA to ensure that these veterans have access to timely and appropriate mental health care, including counseling and therapy. Furthermore, the MVP Act includes provisions to improve data collection and reporting on MST within the VA. This will help to better understand the prevalence of MST among veterans and ensure that the VA is effectively addressing the needs of these individuals. Overall, the MVP Act is aimed at improving the care and support provided to veterans who have experienced MST. By increasing access to mental health services, providing specialized training for VA employees, and improving data collection, this bill seeks to better serve those who have served our country.

Congressional Summary of HR 7389

Medicaid VBPs for Patients Act or the MVP Act

This bill provides statutory authority for regulations that allow for the use of varying best price points under value-based purchasing arrangements for purposes of the Medicaid Drug Rebate Program. (Value-based purchasing arrangements refer to arrangements in which the price of a drug is linked to clinical outcomes; such arrangements are particularly used for new high-cost treatments, such as gene therapies.)

The Government Accountability Office must study the impact of value-based purchasing arrangements on federal health care programs, including with respect to the bill's changes.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 7389

Bill HR 7389 is currently in the status of Bill Introduced since April 4, 2022. Bill HR 7389 was introduced during Congress 117 and was introduced to the House on April 4, 2022. Bill HR 7389's most recent activity was Referred to the Subcommittee on Health. as of April 5, 2022

Bipartisan Support of Bill HR 7389

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 7389

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 7389

MVP Act

Medicaid VBPs for Patients Act

To amend title XIX of the Social Security Act to codify value-based purchasing arrangements under the Medicaid program and reforms related to price reporting under such arrangements, and for other purposes.